KAPA

KAIROS PHARMA LTD

0.97

0.14+16.88%

Pre Market: 0.9700 0.00 0.00%08:58 01/09 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.8100/0.8299

TODAY RANGE0.8100-1.040

VOL486

MARKET CAP20.20M

52 WEEK RANGE0.4000-3.250

AVG VOL (3M)218.42K

% TURNOVER3.61%

TURNOVER0

P/E (TTM)-3.1856

% RANGE25.27%

EPS(TTM)-0.3045

P/E(FORWARD)-3.3448

P/B2.635

BVPS0.3681

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP11.92M

SHARES OUTSTANDING20.82M

NEXT EARNINGS--

FREE FLOAT12.29M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·11/19/2025 16:55
Kairos Pharma’s Promising Clinical Developments and Strategic Focus Drive Buy Rating
Dow Jones·11/19/2025 13:19
Kairos Pharma Is Maintained at Buy by D. Boral Capital
Dow Jones·11/19/2025 13:19
Kairos Pharma Price Target Maintained With a $9.00/Share by D. Boral Capital
Dow Jones·11/04/2025 14:41
Kairos Pharma Is Maintained at Buy by D. Boral Capital
Dow Jones·11/04/2025 14:41
Kairos Pharma Price Target Maintained With a $9.00/Share by D. Boral Capital
NASDAQ·10/20/2025 22:42
D. Boral Capital Maintains Kairos Pharma (KAPA) Buy Recommendation
Dow Jones·10/20/2025 13:38
Kairos Pharma Is Maintained at Buy by D. Boral Capital
Dow Jones·10/20/2025 13:38
Kairos Pharma Price Target Maintained With a $9.00/Share by D. Boral Capital
TipRanks·10/15/2025 20:28
Kairos Pharma Approves RSUs and Cash Bonuses
TipRanks·10/08/2025 17:05
Promising Developments in Kairos Pharma’s Lead Candidate ENV-105 Drive Buy Rating
Dow Jones·10/07/2025 14:57
Kairos Pharma Is Maintained at Buy by D. Boral Capital
Dow Jones·10/07/2025 14:57
Kairos Pharma Price Target Maintained With a $9.00/Share by D. Boral Capital
TipRanks·10/07/2025 12:28
Kairos Pharma to Present at ESMO Congress 2025
TipRanks·09/22/2025 10:25
Promising Phase 2 Results and Safety Profile of ENV-105 Bolster Buy Rating for Kairos Pharma
Dow Jones·09/19/2025 11:26
Kairos Pharma Price Target Maintained With a $9.00/Share by D. Boral Capital

Same Industry

Name/Symbol

Change%

Price

Regeneron Pharmaceuticals

REGN

-1.39%

801.01

GridAI Tech

GRDX

-8.32%

4.52

BIONTECH

BNTX

-1.23%

98.85

United Therapeutics Corp.

UTHR

-2.55%

490.83

Vertex Pharmaceuticals Inc

VRTX

-2.99%

469.68

Siga Technologie

SIGA

-1.17%

6.77

Moderna

MRNA

-5.66%

33.86

Charles Riv Labs Intl Inc

CRL

-0.58%

215.51

Medpace Holdings

MEDP

-2.13%

600.02

Talphera Inc

TLPH

-13.49%

1.09

ICON PLC

ICLR

-7.24%

188.22

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

-0.45%

243.19

MOLECULAR PARTNERS AG

MOLN

-0.28%

4.25

Arcturus Therape

ARCT

-1.02%

6.77

Gilead Sciences Inc

GILD

-2.96%

120.67

PRA Health

PRAH

0.00%

165.21

Incyte Corp

INCY

-4.21%

105.92

Aptevo Therapeutics Inc

APVO

+3.31%

9.20

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.